Activation of the Innate Immune System in Atherosclerotic Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|10|983-994

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.10, 2007-01, pp. : 983-994

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Complement components of the innate immune system in health and disease in the CNS

By Gasque P.   Dean Y.D.   McGreal E.P.   VanBeek J.   Morgan B.P.  

Immunopharmacology, Vol. 49, Iss. 1, 2000-08 ,pp. : 171-186

Elsevier

Access to resources Recommend Favorite

Innate Immunity in the Mucosal Immune System

By  

Current Pharmaceutical Design, Vol. 12, Iss. 32, 2006-11 ,pp. : 4203-4213

Bentham Science Publishers

Access to resources Recommend Favorite

Antimycobacterial activity of Indigofera suffruticosa with activation potential of the innate immune system

By de A. Carli Camila B.   Quilles Marcela B.   Maia Daniele C. G.   Lopes Flávia C. M.   Santos Rubens   Pavan Fernando R.   Fujimura Leite Clarice Q.   Calvo Tamara R.   Vilegas Wagner   Carlos Iracilda Z.  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 48, Iss. 8, 2010-08 ,pp. : 878-882

Informa Healthcare

Access to resources Recommend Favorite

Stimulation of the innate immune system: a paradigm for the future identification of disease modifying agents to treat asthma and allergic diseases

By Williams R.J.  

Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 3, 2000-06 ,pp. : 313-321

Informa Healthcare

Access to resources Recommend Favorite

Cystic Fibrosis and the Innate Immune System: Therapeutic Implications

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 11, Iss. 1, 2011-03 ,pp. : 8-22

Bentham Science Publishers

Access to resources Recommend Favorite